Biological Therapeutic Products

Conferences & Courses
Blood-Brain Barrier Blood-Brain Barrier
June 10-11, 2015 | Boston, MA
The blood-brain barrier (BBB) maintains essential brain homeostasis, but as a result can impede delivery of new therapies.

Targeting GPCRs Targeting GPCRs
June 10-11, 2015 | Boston, MA
G-Protein Coupled Receptors (GPCRs) because of their role in many medically-relevant pathways, are attractive targets for pharmacological modulation.

Tumor Models for Cancer Immunotherapy Tumor Models for Cancer Immunotherapy
June 11-12, 2015 | Boston, MA
The immune system can be programmed to recognize and destroy cancerous cells infected by viruses or affected by transforming genetic or epigenetic alterations.




Life Science Media Library
Introduction to Adoptive T Cell Therapies DVD Introduction to Adoptive T Cell Therapies DVD
May 5, 2014 |
Adoptive T cell therapy has the potential to increase antitumor immunity, enhance vaccine efficacy, and limit graft-versus-host disease (GVHD). Recent advances in protein engineering and molecular biology have increased the feasibility of using genetically engineered T cells to treat disease, leading to an influx of new discoveries and techniques. This course DVD will educate viewers on the basic rules of adoptive T cell therapies before delving into strategies for developing chimeric antigen receptors (CARs) and T cell receptors (TCRs).
Phage & Yeast Display Libraries Phage & Yeast Display Libraries
May 4, 2014 |
This workshop is meant to bring the scientist up to speed on the display technologies covered by the main conference and is tailored for both the novice and those with experience in display technologies. The workshop will provide an overview of: Phage display and construction of phage-displayed scFv and Fab libraries Yeast display and construction of yeast-displayed scFv and Fab libraries Selection and screening technologies that are compatible with phage and yeast-display libraries Combining phage and yeast display for antibody selection and epitope identification Integrating deep sequencing into the antibody selection pipeline
Accelerated Stability Testing of Biologics Accelerated Stability Testing of Biologics
August 20, 2013 |
This digital course will aim to guide the researcher in designing studies for accelerated stability testing of biologics. The course will begin with basic underlying concepts governing protein drug product stability, and focus on design principles for meaning stress and accelerated stability testing of not only the protein of interest but also of excipients and primary packaging components. Strategies to handle complexities arising from their interactions will also be discussed.




Publications, Reports, & Whitepapers
Prenatal Diagnostics: Invasive testing, noninvasive testing, and rising maternal screening methods for preeclampsia and preterm labor
New to insight Pharma Reports is Prenatal Diagnostics: Invasive testing, noninvasive testing, and rising maternal screening methods for preeclampsia and preterm labor. This report discusses improvements in invasive procedures (karyotyping vs. cytogenetics), and the rise of noninvasive screening methods and their impact on prenatal healthcare.
Vaccines: The End of Illness
This report analyzes recent trends in medicinal chemistry and evaluates their significance for advancing R&D productivity. We consider technological modalities and market dynamics, with an emphasis on outsourcing and user views on the implications of current practices.
Ocular Disorders: Rising Therapeutics, Technologies, and Devices
New to Insight Pharma Reports is: Ocular Disorders: Rising Therapeutics, Technologies, and Devices. This report covers several companies and their approach to targeting ocular diseases including wet and dry age-related macular degeneration (AMD) while also providing alternative therapeutic options for various ocular complications.